Pure Global

Profhilo® Structura 4.5% - 45 mg (H-HA) + 45 mg (L-HA)/2 mL Hyaluronic acid sodium salt pre-filled syringe - FDA Registration CMDR-2025-04649

Access comprehensive regulatory information for Profhilo® Structura 4.5% - 45 mg (H-HA) + 45 mg (L-HA)/2 mL Hyaluronic acid sodium salt pre-filled syringe in the Philippines medical device market through Pure Global AI's free database. This device is registered under FDA registration number CMDR-2025-04649 and manufactured by IBSA Farmaceutici Italia Srl- Via Martiri di Cefalonia, 2 26900 Lodi, Italy in Italy. The device was registered on May 14, 2025.

This page provides complete registration details including manufacturer information, importer/distributor details (Metro Drug, Inc.), and regulatory compliance data from the official Philippines FDA medical device database. Pure Global AI offers free access to Philippines' complete medical device registry, helping global MedTech companies navigate FDA regulations efficiently.

Free Database
Powered by Pure Global AI
FDA Official Data
Italy
CMDR-2025-04649
Profhilo® Structura 4.5% - 45 mg (H-HA) + 45 mg (L-HA)/2 mL Hyaluronic acid sodium salt pre-filled syringe
Registered medical device in Philippines
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Information
Product Name
Profhilo® Structura 4.5% - 45 mg (H-HA) + 45 mg (L-HA)/2 mL Hyaluronic acid sodium salt pre-filled syringe
Registration Number
CMDR-2025-04649
Manufacturer Details
Importer & Distribution
Importer/Distributor
Metro Drug, Inc.
Registration Dates
Issuance Date
May 14, 2025
Expiry Date
May 14, 2030